Exovir Inc European Patent Office notify application cover combination nonionic surfactant form interferon approve patent issue six months. Exovir complete trial gel combine alpha interferon nonoxynol-9 antiviral surfactant treatment genital oral herpes genital warts. The gel U.S. patent 1985. It clinical test begin shortly test whether gel effective prevent transmission AIDS virus condom. Reuter 